Literature DB >> 30016459

Histological Features of Cerebellar Neuropathology in Patients With Alcoholic and Nonalcoholic Steatohepatitis.

Tiziano Balzano1, Jerónimo Forteza2, Irene Borreda2, Pilar Molina3,4, Juan Giner3, Paola Leone1, Amparo Urios1, Carmina Montoliu4,5, Vicente Felipo1.   

Abstract

Alcoholic steatohepatitis (ASH) and nonalcoholic steatohepatitis (NASH) affect 29 million people in the European Union. Patients with ASH and NASH may exhibit cognitive impairment, reducing their quality of life. Steatohepatitis induces cerebral alterations. It is not known if histological analysis could allow distinguishing ASH, NASH, and/or cirrhosis neuropathology and other entities. The aim of this work was to analyze a set of histopathological features characterizing the brain lesions due to ASH, NASH, and cirrhosis. We performed a histological study using hematoxylin and eosin staining and immunohistochemical techniques in cerebellum of 31 subjects who died with healthy liver (n = 6), NASH (n = 14), ASH (n = 3), nonalcoholic cirrhosis (n = 4), and alcoholic cirrhosis (n = 4). We analyzed in cerebellum, as an early marker for brain injury: 1) vascular damage; 2) cerebellar atrophy and neurodegeneration in Purkinje layer; and 3) microglia and astrocytes activation in white matter and molecular layer. Patients with steatohepatitis have increased number of microtrombi in cerebellar parenchyma, neuronal loss in Purkinje layer and microglial and astrocyte activation in white matter and molecular layer. These alterations are stronger in patients with ASH than in those with NASH. These results provide a set of histopathological features in brain that may allow differentiation of steatohepatitis from other conditions.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30016459     DOI: 10.1093/jnen/nly061

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  8 in total

1.  Non-alcoholic Fatty Liver Disease: Also a Disease of the Brain? A Systematic Review of the Preclinical Evidence.

Authors:  Anne Catrine Daugaard Mikkelsen; Kristoffer Kjærgaard; Rajeshwar Prosad Mookerjee; Hendrik Vilstrup; Gregers Wegener; Cecilie Bay-Richter; Karen Louise Thomsen
Journal:  Neurochem Res       Date:  2022-03-01       Impact factor: 3.996

Review 2.  Diabetes mellitus - risk factor and potential future target for hepatic encephalopathy in patients with liver cirrhosis?

Authors:  Simon Johannes Gairing; Eva Maria Schleicher; Christian Labenz
Journal:  Metab Brain Dis       Date:  2022-08-24       Impact factor: 3.655

Review 3.  Management of Hepatic Encephalopathy Associated with Advanced Liver Disease.

Authors:  Rita García-Martínez; Raquel Diaz-Ruiz; Marta Poncela
Journal:  Clin Drug Investig       Date:  2022-05-10       Impact factor: 3.580

Review 4.  Fatty liver and cerebrovascular disease: plausible association and possible mechanisms.

Authors:  Sahil Khanna; Neal S Parikh; Lisa B VanWagner
Journal:  Curr Opin Lipidol       Date:  2022-02-01       Impact factor: 4.616

5.  A multi-omic study for uncovering molecular mechanisms associated with hyperammonemia-induced cerebellar function impairment in rats.

Authors:  Sonia Tarazona; Héctor Carmona; Ana Conesa; Marta Llansola; Vicente Felipo
Journal:  Cell Biol Toxicol       Date:  2021-01-06       Impact factor: 6.691

Review 6.  Cognitive Dysfunction in Non-Alcoholic Fatty Liver Disease-Current Knowledge, Mechanisms and Perspectives.

Authors:  Kristoffer Kjærgaard; Anne Catrine Daugaard Mikkelsen; Charlotte Wilhelmina Wernberg; Lea Ladegaard Grønkjær; Peter Lykke Eriksen; Malene Flensborg Damholdt; Rajeshwar Prosad Mookerjee; Hendrik Vilstrup; Mette Munk Lauridsen; Karen Louise Thomsen
Journal:  J Clin Med       Date:  2021-02-09       Impact factor: 4.241

7.  Fiber scaffold bioartificial liver therapy relieves acute liver failure and extrahepatic organ injury in pigs.

Authors:  Jun Weng; Xu Han; Fanhong Zeng; Yue Zhang; Lei Feng; Lei Cai; Kangyan Liang; Shusong Liu; Shao Li; Gongbo Fu; Min Zeng; Yi Gao
Journal:  Theranostics       Date:  2021-06-11       Impact factor: 11.556

8.  Sustained hyperammonemia induces TNF-a IN Purkinje neurons by activating the TNFR1-NF-κB pathway.

Authors:  Tiziano Balzano; Yaiza M Arenas; Sherry Dadsetan; Jerónimo Forteza; Sara Gil-Perotin; Laura Cubas-Nuñez; Bonaventura Casanova; Francisco Gracià; Natalia Varela-Andrés; Carmina Montoliu; Marta Llansola; Vicente Felipo
Journal:  J Neuroinflammation       Date:  2020-02-22       Impact factor: 8.322

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.